Manager, QC Sample Management at Bristol-Myers Squibb

Drogheda, County Meath, Ireland

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Minimum of a B.Sc. in Biochemistry or related discipline
At least 5 years’ experience in a GMP laboratory setting with sample management experience
Understanding of the needs and best practices of routine biopharmaceutical drug product and drug substance laboratories (desirable)
Demonstrated leadership ability and flexibility
Good communication and team-work skills
Excellent communication skills
Ability to communicate on a global level
Experience in electronic systems such as LIMs/CIMs, Trackwise/Infinity and SAP
Demonstrated experience in corporate and regulatory audits

Responsibilities

Responsible for the sample management process for all QC activities for Global Biologics Laboratory and MPCC
Management of the Retains Programs
Ensure adherence to sample chain of custody in Cruiserath Biologics Laboratory
Leading and engaging a team of materials management personnel and recruiting where necessary
Co-ordination of sample shipments with internal and external stakeholders to support testing schedules, drug substance release, raw material release and stability programs
Management of investigations associated with sample handling, receipt, long term storage, retains and raw materials
Management of sample temperature tracking devices, shipping documentation, electronic and paper logbooks, LIMs/CIMs data
Ensure all sample management procedures are aligned with corporate and regulatory procedures
Ensure all laboratory activities are conducted in a safe manner
Support of raw material testing in terms of batch approval, investigations and recruitment

Skills

Sample Management

Quality Control

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free